Activation of calpain in cultured neurons overexpressing Alzheimer amyloid precursor protein

Molecular Brain Research

Volumn 107, Issue 2, 2002, Pages 166-175

  Kuwako, Ken Ichiro ^a   Nishimura, Isao ^a   Uetsuki, Taichi ^a   Saido, Takaomi C ^b   Yoshikawa, Kazuaki ^a  

^a OSAKA UNIVERSITY   (Japan)

^b RIKEN BRAIN SCIENCE INSTITUTE   (Japan)

Author keywords

Alzheimer's disease; Apoptosis; APP; Calcium homeostasis; Calpain; Caspase 3; Neurons

Indexed keywords

ADENOVIRUS VECTOR; ALOXISTATIN; AMYLOID PRECURSOR PROTEIN; CALCIUM ION; CALPAIN; CALPASTATIN; CASPASE 3; ENZYME INHIBITOR; FODRIN; MUTANT PROTEIN; N ACETYLLEUCYLLEUCYLMETHIONINAL; N ACETYLLEUCYLLEUCYLNORLEUCINAL; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ARTICLE; CALCIUM CELL LEVEL; CANCER CELL CULTURE; CELL DEATH; CHELATION; CONTROLLED STUDY; ENZYME ACTIVATION; GENE OVEREXPRESSION; GENE TRANSFER; HUMAN; HUMAN CELL; MITOSIS; NERVE CELL CULTURE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DOMAIN;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN PRECURSOR; BRAIN; CALCIUM; CALCIUM SIGNALING; CALPAIN; CASPASE 3; CASPASES; CELL DEATH; CHELATING AGENTS; ENZYME INHIBITORS; GENE EXPRESSION; GENETIC VECTORS; HUMANS; IMMUNOHISTOCHEMISTRY; IONOPHORES; MUTATION; NEURONS; TRANSFECTION; TUMOR CELLS, CULTURED; UP-REGULATION;

ADENOVIRIDAE;

EID: 0037112117     PISSN: 0169328X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-328X(02)00489-8     Document Type: Article

References (49)

1. Andrews P.W. Retinoic acid induces neuronal differentiation of a cloned human embryonal carcinoma cell line in vitro. Dev. Biol. 103:1984;285-293.
2. Barnes N.Y., Li L., Yoshikawa K., Schwartz L.M., Oppenheim R.W., Milligan C.E. Increased production of amyloid precursor protein provides a substrate for caspase-3 in dying motoneurons. J. Neurosci. 18:1998;5869-5880.
3. Benowitz L.I., Rodriguez W., Paskevich P., Mufson E.J., Schenk D., Neve R.L. The amyloid precursor protein is concentrated in neuronal lysosomes in normal and Alzheimer disease subjects. Exp. Neurol. 106:1989;237-250.
4. Blomgren K., Zhu C., Wang X., Karlsson J.O., Leverin A.L., Bahr B.A., Mallard C., Hagberg H. Synergistic activation of caspase-3 by m-calpain after neonatal hypoxia-ischemia: a mechanism of 'pathological apoptosis'? J. Biol. Chem. 276:2001;10191-10198.
5. Bursztajn S., DeSouza R., McPhie D.L., Berman S.A., Shioi J., Robakis N.K., Neve R.L. Overexpression in neurons of human presenilin-1 or a presenilin-1 familial Alzheimer disease mutant does not enhance apoptosis. J. Neurosci. 18:1998;9790-9799.
6. Chen J., Nagayama T., Jin K., Stetler R.A., Zhu R.L., Graham S.H., Simon R.P. Induction of caspase-3-like protease may mediate delayed neuronal death in the hippocampus after transient cerebral ischemia. J. Neurosci. 18:1998;4914-4928.
7. Chua B.T., Guo K., Li P. Direct cleavage by the calcium-activated protease calpain can lead to inactivation of caspases. J. Biol. Chem. 275:2000;5131-5135.
8. Cole G.M., Masliah E., Shelton E.R., Chan H.W., Terry R.D., Saitoh T. Accumulation of amyloid precursor fragment in Alzheimer plaques. Neurobiol. Aging. 12:1991;85-91.
9. Croall D.E., DeMartino G.N. Calcium-activated neutral protease (calpain) system: structure, function, and regulation. Physiol. Rev. 71:1991;813-847.
10. Cummings B.J., Su J.H., Geddes J.W., Van Nostrand W.E., Wagner S.L., Cunningham D.D., Cotman C.W. Aggregation of the amyloid precursor protein within degenerating neurons and dystrophic neurites in Alzheimer's disease. Neuroscience. 48:1992;763-777.
11. Glenner G.G., Wong C.W. Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem. Biophys. Res. Commun. 120:1984;885-890.
12. Grynspan F., Griffin W.R., Cataldo A., Katayama S., Nixon R.A. Active site-directed antibodies identify calpain II as an early-appearing and pervasive component of neurofibrillary pathology in Alzheimer's disease. Brain Res. 763:1997;145-158.
13. Kim H.S., Park C.H., Cha S.H., Lee J.H., Lee S., Kim Y., Rah J.C., Jeong S.J., Suh Y.H. Carboxyl-terminal fragment of Alzheimer's APP destabilizes calcium homeostasis and renders neuronal cells vulnerable to excitotoxicity. FASEB J. 14:2000;1508-1517.
14. Masumura M., Hata R., Nishimura I., Uetsuki T., Sawada T., Yoshikawa K. Caspase-3 activation and inflammatory responses in rat hippocampus inoculated with a recombinant adenovirus expressing the Alzheimer amyloid precursor protein. Brain Res. Mol. Brain Res. 80:2000;219-227.
15. Mattson M.P. Cellular actions of beta-amyloid precursor protein and its soluble and fibrillogenic derivatives. Physiol. Rev. 77:1997;1081-1132.
16. McGinnis K.M., Gnegy M.E., Park Y.H., Mukerjee N., Wang K.K. Procaspase-3 and poly(ADP)ribose polymerase (PARP) are calpain substrates. Biochem. Biophys. Res. Commun. 263:1999;94-99.
17. 2+ influx. J. Biol. Chem. 271:1996;9332-9339.
18. Milligan C.E., Prevette D., Yaginuma H., Homma S., Cardwell C., Fritz L.C., Tomaselli K.J., Oppenheim R.W., Schwartz L.M. Peptide inhibitors of the ICE protease family arrest programmed cell death of motoneurons in vivo and in vitro. Neuron. 15:1995;385-393.
19. Nakagawa T., Yuan J. Cross-talk between two cysteine protease families. Activation of caspase-12 by calpain in apoptosis. J. Cell Biol. 150:2000;887-894.
20. Namura S., Zhu J., Fink K., Endres M., Srinivasan A., Tomaselli K.J., Yuan J., Moskowitz M.A. Activation and cleavage of caspase-3 in apoptosis induced by experimental cerebral ischemia. J. Neurosci. 18:1998;3659-3668.
21. Neve R.L., McPhie D.L., Chen Y. Alzheimer's disease: a dysfunction of the amyloid precursor protein. Brain Res. 886:2000;54-66.
22. Newcomb-Fernandez J.K., Zhao X., Pike B.R., Wang K.K., Kampfl A., Beer R., DeFord S.M., Hayes R.L. Concurrent assessment of calpain and caspase-3 activation after oxygen-glucose deprivation in primary septo-hippocampal cultures. J. Cereb. Blood Flow Metab. 21:2001;1281-1294.
23. Nicholson D.W., Ali A., Thornberry N.A., Vaillancourt J.P., Ding C.K., Gallant M., Gareau Y., Griffin P.R., Labelle M., Lazebnik Y.A., Munday N.A., Raju S.M., Smulson M.E., Yamin T., Yu V.L., Miller D.K. Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature. 376:1995;37-43.
24. Nilsson E., Alafuzoff I., Blennow K., Blomgren K., Hall C.M., Janson I., Karlsson I., Wallin A., Gottfries C.G., Karlsson J.O. Calpain and calpastatin in normal and Alzheimer-degenerated human brain tissue. Neurobiol. Aging. 11:1990;425-431.
25. Nishimura I., Uetsuki T., Dani S.U., Ohsawa Y., Saito I., Okamura H., Uchiyama Y., Yoshikawa K. Degeneration in vivo of rat hippocampal neurons by wild-type Alzheimer amyloid precursor protein overexpressed by adenovirus-mediated gene transfer. J. Neurosci. 18:1998;2387-2398.
26. Nishimura I., Uetsuki T., Kuwako K., Hara T., Kawakami T., Aimoto S., Yoshikawa K. Cell death induced by a caspase-cleaved transmembrane fragment of the Alzheimer amyloid precursor protein. Cell Death Differ. 9:2002;199-208.
27. Pascale A., Bhagavan S., Nelson T.J., Neve R.L., McPhie D.L., Etcheberrigaray R. Enhanced BK-induced calcium responsiveness in PC12 cells expressing the C100 fragment of the amyloid precursor protein. Brain Res. Mol. Brain Res. 72:1999;205-213.
28. Perez R.G., Zheng H., Van der Ploeg L.H., Koo E.H. The beta-amyloid precursor protein of Alzheimer's disease enhances neuron viability and modulates neuronal polarity. J. Neurosci. 17:1997;9407-9414.
29. Pleasure S.J., Page C., Lee V.M. Pure, postmitotic, polarized human neurons derived from NTera 2 cells provide a system for expressing exogenous proteins in terminally differentiated neurons. J. Neurosci. 12:1992;1802-1815.
30. Ruiz-Vela A., Gonzalez de Buitrago G., Martinez A.C. Implication of calpain in caspase activation during B cell clonal deletion. EMBO J. 18:1999;4988-4998.
31. Saido T.C., Nagao S., Shiramine M., Tsukaguchi M., Sorimachi H., Murofushi H., Tsuchiya T., Ito H., Suzuki K. Autolytic transition of mu-calpain upon activation as resolved by antibodies distinguishing between the pre- and post-autolysis forms. J. Biochem. (Tokyo). 111:1992;81-86.
32. Saido T.C., Sorimachi H., Suzuki K. Calpain: new perspectives in molecular diversity and physiological-pathological involvement. FASEB J. 8:1994;814-822.
33. Saido T.C., Yokota M., Maruyama K., Yamao-Harigaya W., Tani E., Ihara Y., Kawashima S. Spatial resolution of the primary beta-amyloidogenic process induced in postischemic hippocampus. J. Biol. Chem. 269:1994;15253-15257.
34. Saido T.C., Yokota M., Nagao S., Yamaura I., Tani E., Tsuchiya T., Suzuki K., Kawashima S. Spatial resolution of fodrin proteolysis in postischemic brain. J. Biol. Chem. 268:1993;25239-25243.
35. Saito K., Elce J.S., Hamos J.E., Nixon R.A. Widespread activation of calcium-activated neutral proteinase (calpain) in the brain in Alzheimer disease: a potential molecular basis for neuronal degeneration. Proc. Natl. Acad. Sci. USA. 90:1993;2628-2632.
36. Selkoe D.J. Normal and abnormal biology of the beta-amyloid precursor protein. Annu. Rev. Neurosci. 17:1994;489-517.
37. Selznick L.A., Holtzman D.M., Han B.H., Gokden M., Srinivasan A.N., Johnson E.M. Jr., Roth K.A. In situ immunodetection of neuronal caspase-3 activation in Alzheimer disease. J. Neuropathol. Exp. Neurol. 58:1999;1020-1026.
38. Stadelmann C., Deckwerth T.L., Srinivasan A., Bancher C., Brok W., Jellinger K., Lassmann H. Activation of caspase-3 in single neurons and autophagic granules of granulovacuolar degeneration in Alzheimer's disease: evidence for apoptotic cell death. Am. J. Pathol. 155:1999;1459-1466.
39. Stephenson D.T., Rash K., Clemens J.A. Amyloid precursor protein accumulates in regions of neurodegeneration following focal cerebral ischemia in the rat. Brain Res. 593:1992;128-135.
40. Tominaga K., Uetsuki T., Ogura A., Yoshikawa K. Glutamate responsiveness enhanced in neurones expressing amyloid precursor protein. Neuroreport. 8:1997;2067-2072.
41. Uetsuki T., Takemoto K., Nishimura I., Okamoto M., Niinobe M., Momoi T., Miura M., Yoshikawa K. Activation of neuronal caspase-3 by intracellular accumulation of wild-type Alzheimer amyloid precursor protein. J. Neurosci. 19:1999;6955-6964.
42. Van Nostrand W.E., Wagner S.L., Suzuki M., Choi B.H., Farrow J.S., Geddes J.W., Cotman C.W., Cunningham D.D. Protease nexin-II, a potent antichymotrypsin, shows identity to amyloid beta-protein precursor. Nature. 341:1989;546-549.
43. Volbracht C., Fava E., Leist M., Nicotera P. Calpain inhibitors prevent nitric oxide-triggered excitotoxic apoptosis. Neuroreport. 12:2001;3645-3648.
44. Waterhouse N.J., Finucane D.M., Green D.R., Elce J.S., Kumar S., Alnemri E.S., Litwack G., Khanna K., Lavin M.F., Watters D.J. Calpain activation is upstream of caspases in radiation-induced apoptosis. Cell Death Differ. 5:1998;1051-1061.
45. Wolf B.B., Goldstein J.C., Stennicke H.R., Beere H., Amarante-Mendes G.P., Salvesen G.S., Green D.R. Calpain functions in a caspase-independent manner to promote apoptosis-like events during platelet activation. Blood. 94:1999;1683-1692.
46. Wood D.E., Newcomb E.W. Caspase-dependent activation of calpain during drug-induced apoptosis. J. Biol. Chem. 274:1999;8309-8315.
47. Xu X., Yang D., Wyss-Coray T., Yan J., Gan L., Sun Y., Mucke L. Wild-type but not Alzheimer-mutant amyloid precursor protein confers resistance against p53-mediated apoptosis. Proc. Natl. Acad. Sci. USA. 96:1999;7547-7552.
48. Yankner B.A. Mechanisms of neuronal degeneration in Alzheimer's disease. Neuron. 16:1996;921-932.
49. Yoshikawa K., Aizawa T., Hayashi Y. Degeneration in vitro of post-mitotic neurons overexpressing the Alzheimer amyloid protein precursor. Nature. 359:1992;64-67.